Biogen, Inc.
(NASDAQ : BIIB)

( )
BIIB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1888.07m
AMGNAmgen, Inc. -2.43%197.811.3%$881.42m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$848.08m
BIIBBiogen, Inc. -7.31%293.271.5%$703.75m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$557.47m
MRNAModerna, Inc. -0.94%29.670.0%$530.64m
ILMNIllumina, Inc. -6.10%256.463.5%$443.43m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$286.49m
AAgilent Technologies, Inc. -3.67%68.991.6%$220.20m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$187.28m
INCYIncyte Corp. 1.30%74.182.5%$178.88m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$164.58m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$163.42m
NVAXNovavax, Inc. 3.31%14.03114.7%$128.96m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$98.37m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.